Stem cell experiments moves into clinic: New hope for children with bronchopulmonary dysplasia

Advances in Experimental Medicine and Biology

Volumn 839, Issue , 2015, Pages 47-53

  Pawelec, K ^a,b   Gladysz D ^a   Demkow, U ^a,b  

^a Polish Stem Cell Bank   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Lung diseases; Mesenchymal stem cell; Prematurity; Umbilical cord; Wharton s jelly

Indexed keywords

COLLAGEN TYPE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSFER; COLONY FORMING CELL; ENDOTHELIAL PROGENITOR CELL; ENGRAFTMENT; HUMAN; IMMUNOPHENOTYPING; LUNG DYSPLASIA; LUNG LAVAGE; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STEM CELL TRANSPLANTATION; TREATMENT DURATION; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; ANIMAL; ARTIFICIAL VENTILATION; BRONCHOPULMONARY DYSPLASIA; CLINICAL TRIAL (TOPIC); CYTOLOGY; ENDOTRACHEAL INTUBATION; INFANT; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; NEWBORN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREMATURITY; PROCEDURES; RAT; UMBILICAL CORD;

ANIMALS; BRONCHOPULMONARY DYSPLASIA; CLINICAL TRIALS AS TOPIC; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INTUBATION, INTRATRACHEAL; LUNG; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; RATS; RESPIRATION, ARTIFICIAL; UMBILICAL CORD;

EID: 84925024397     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/5584_2014_27     Document Type: Article

References (24)

1. Ahn SY, Chang YS, Kim SY, Sung DK, Kim ES, Rime SY, Yu WJ, Choi SJ, Oh WI, Park WS (2013) Long-term (postnatal day 70) outcome and safety of intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells in neonatal hyperoxic lung injury. Yonsei Med J 54(2):416-424
2. Aslam M, Baveja R, Liang OD, Fernandez-Gonzalez A, Lee C, Mitsialis SA, Kourembanas S (2009) Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease. Am J Respir Crit Care Med 180(11):1122-1130
3. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH (2007) Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292(5):1073-1084
4. Bancalari E, Claure N, Sosenko IR (2003) Bronchopulmonary dysplasia: changes in pathogenesis, epidemiology and definition. Semin Neonatol 8 (1):63-71
5. Borghesi A, Massa M, Campanelli R, Bollani L, Tzialla C, Figar TA, Ferrari G, Bonetti E, Chiesa G, de Silvestri A, Spinillo A, Rosti V, Stronati M (2009) Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia. Am J Respir Crit Care Med 180(6):540-546
6. Borghesi A, Maragliano R, Campanelli R, Manzoni P, Maccario R, Stronati M (2012) Stem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infants. Early Hum Dev 88(Suppl 2):75-77
7. Chang YS, Oh W, Choi SJ, Sung DK, Kim SY, Choi EY, Kang S, Jin HJ, Yang YS, Park WS (2009) Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats. Cell Transplant 18(8):869-886
8. Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, Park WS (2011) Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxiainduced lung injury in neonatal rats. Cell Transplant 20(11-12):1843-1854
9. De Paepe ME, Mao Q, Ghanta S, Hovanesian V, Padbury JF (2011) Alveolar epithelial cell therapy with human cord blood-derived hematopoietic progenitor cells. Am J Pathol 178(3):1329-1339
10. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317
11. Donohue PK, Gilmore MM, Cristofalo E, Wilson RF, Weiner JZ, Lau BD, Robinson KA, Allen MC (2011) Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127(2):414-422
12. Kaukola T, Tuimala J, Herva R, Kingsmore S, HallmanM (2009) Cord immunoproteins as predictors of respiratory outcome in preterm infants. Am J Obstet Gynecol 200(1):100.e1-100.e8
13. Kern S, Eichler H, Stoeve J, Klüter H, Bieback K (2006) Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24(5):1294-1301
14. Mao Q, Chu S, Ghanta S, Padbury JF, De Paepe ME (2013) Ex vivo expanded human cord blood-derived hematopoietic progenitor cells induce lung growth and alveolarization in injured newborn lungs. Respir Res 14:37
15. O'Reilly M, Sozo F, Harding R (2013) The impact of preterm birth and bronchopulmonary dysplasia on the developing lung: long-term consequences for respiratory health. Clin Exp Pharmacol Physiol 40(11):765-773
16. Ortiz LA, Durrell M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A 104 (26):11002-11007
17. Pierro M, Ionescu L, Montemurro T, Vadivel A, Weissmann G, Oudit G, Emery D, Bodiga S, Eaton F, Péault B, Mosca F, Lazzari L, Thébaud B (2013) Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia. Thorax 68(5):475-484
18. Sutsko RP, Young KC, Ribeiro A, Torres E, Rodriguez M, Hehre D, Devia C, McNiece I, Suguihara C (2013) Long-term reparative effects of mesenchymal stem cell therapy following neonatal hyperoxia-induced lung injury. Pediatr Res 73(1):46-53
19. Tropea KA, Leder E, Aslam M, Lau AN, Raiser DM, Lee JH, Balasubramaniam V, Fredenburgh LE, Alex Mitsialis S, Kourembanas S, Kim CF (2012) Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia. Lung Cell Mol Physiol 302(9):829-837
20. Van Haaften T, Byrne R, Bonnet S, Rochefort GY, Akabutu J, Bouchentouf M, Rey-Parra GJ, Galipeau J, Haromy A, Eaton F, Chen M, Hashimoto K, Abley D, Korbutt G, Archer SL, Thébaud B (2009) Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats. Am J Respir Crit Care Med 180(11):1131-1142
21. Van Marter LJ (2009) Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med 14(6):358-366
22. Van Marter LJ, Kuban KC, Allred E, Bose C, Dammann O, O'Shea M, Laughon M, Ehrenkranz RA, Schreiber MD, Karna P, Leviton A, ELGAN Study Investigators (2011) Does bronchopulmonary dysplasia contribute to the occurrence of cerebral palsy among infants born before 28 weeks of gestation? Arch Dis Child Fetal Neonatal Ed 96(1):F20-F29
23. Wright CJ, Kirpalani H (2011) Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies? Pediatrics 128(1):111-126
24. Zhang X, Wang H, Shi Y, Peng W, Zhang S, Zhang W, Xu J, Mei Y, Feng Z (2012) Role of bone marrowderived mesenchymal stem cells in the prevention of hyperoxia-induced lung injury in newborn mice. Cell Biol Int 36(6):589-594